Phosphorylation-Dependent Inhibition of Akt1

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2018 Sep 13

PMID 30205513

Citations 18

Authors

Nileeka Balasuriya

McShane McKenna

Xuguang Liu

Shawn S C Li

Patrick ODonoghue

Affiliations

Soon will be listed here.

Abstract

Protein kinase B (Akt1) is a proto-oncogene that is overactive in most cancers. Akt1 activation requires phosphorylation at Thr308; phosphorylation at Ser473 further enhances catalytic activity. Akt1 activity is also regulated via interactions between the kinase domain and the N-terminal auto-inhibitory pleckstrin homology (PH) domain. As it was previously difficult to produce Akt1 in site-specific phosphorylated forms, the contribution of each activating phosphorylation site to auto-inhibition was unknown. Using a combination of genetic code expansion and in vivo enzymatic phosphorylation, we produced Akt1 variants containing programmed phosphorylation to probe the interplay between Akt1 phosphorylation status and the auto-inhibitory function of the PH domain. Deletion of the PH domain increased the enzyme activity for all three phosphorylated Akt1 variants. For the doubly phosphorylated enzyme, deletion of the PH domain relieved auto-inhibition by 295-fold. We next found that phosphorylation at Ser473 provided resistance to chemical inhibition by Akti-1/2 inhibitor VIII. The Akti-1/2 inhibitor was most effective against pAkt1 and showed four-fold decreased potency with Akt1 variants phosphorylated at Ser473. The data highlight the need to design more potent Akt1 inhibitors that are effective against the doubly phosphorylated and most pathogenic form of Akt1.

Citing Articles

The chemical composition analysis of Yixin Tongmai Granules using UHPLC-MS/MS and exploration of its potential mechanism in treatment of coronary artery disease based on network pharmacology and molecular docking.

Li H, Zhu Y Medicine (Baltimore). 2025; 104(8):e41620.

PMID: 39993113 PMC: 11856895. DOI: 10.1097/MD.0000000000041620.

Flavonoids of Diels et Gilg Against Acute Hepatic Injury by Blocking PI3K/AKT Signaling Pathway.

Li L, Zhan L, Wu X, Jiang X, Pu J Mediators Inflamm. 2025; 2025():4302130.

PMID: 39816675 PMC: 11732288. DOI: 10.1155/mi/4302130.

Genetic Encoding of Phosphorylated Amino Acids into Proteins.

Allen M, Karplus P, Mehl R, Cooley R Chem Rev. 2024; 124(10):6592-6642.

PMID: 38691379 PMC: 11658404. DOI: 10.1021/acs.chemrev.4c00110.

Inhibition of lncRNA NFIA-AS1 Alleviates Abnormal Proliferation and Inflammation of Vascular Smooth Muscle Cells in Atherosclerosis by Regulating miR-125a-3p/AKT1 Axis.

Zhu Y, Tian X, Wang Y, Wang C, Yang N, Ying L Int J Genomics. 2023; 2023:8437898.

PMID: 37056786 PMC: 10089782. DOI: 10.1155/2023/8437898.

Delivery of Active AKT1 to Human Cells.

Siddika T, Balasuriya N, Frederick M, Rozik P, Heinemann I, ODonoghue P Cells. 2022; 11(23).

PMID: 36497091 PMC: 9738475. DOI: 10.3390/cells11233834.

References

Zhang X, Zhang S, Yamane H, Wahl R, Ali A, Lofgren J . Kinetic mechanism of AKT/PKB enzyme family. J Biol Chem. 2006; 281(20):13949-56. DOI: 10.1074/jbc.M601384200. View

Kunkel M, Ni Q, Tsien R, Zhang J, Newton A . Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter. J Biol Chem. 2004; 280(7):5581-7. PMC: 2913970. DOI: 10.1074/jbc.M411534200. View

Lindsley C, Zhao Z, Leister W, Robinson R, Barnett S, Defeo-Jones D . Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. Bioorg Med Chem Lett. 2005; 15(3):761-4. DOI: 10.1016/j.bmcl.2004.11.011. View

Klein S, Geiger T, Linchevski I, Lebendiker M, Itkin A, Assayag K . Expression and purification of active PKB kinase from Escherichia coli. Protein Expr Purif. 2005; 41(1):162-9. DOI: 10.1016/j.pep.2005.01.003. View

Lu M, Wan M, Leavens K, Chu Q, Monks B, Fernandez S . Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med. 2012; 18(3):388-95. PMC: 3296881. DOI: 10.1038/nm.2686. View

Fabbro D, Batt D, Rose P, Schacher B, Roberts T, Ferrari S . Homogeneous purification of human recombinant GST-Akt/PKB from Sf9 cells. Protein Expr Purif. 1999; 17(1):83-8. DOI: 10.1006/prep.1999.1102. View

Balasuriya N, Kunkel M, Liu X, Biggar K, Li S, Newton A . Genetic code expansion and live cell imaging reveal that Thr-308 phosphorylation is irreplaceable and sufficient for Akt1 activity. J Biol Chem. 2018; 293(27):10744-10756. PMC: 6036199. DOI: 10.1074/jbc.RA118.002357. View

Wu W, Voegtli W, Sturgis H, Dizon F, Vigers G, Brandhuber B . Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition. PLoS One. 2010; 5(9):e12913. PMC: 2944833. DOI: 10.1371/journal.pone.0012913. View

Hart J, Vogt P . Phosphorylation of AKT: a mutational analysis. Oncotarget. 2011; 2(6):467-76. PMC: 3139455. DOI: 10.18632/oncotarget.293. View

10.

Agarwal E, Brattain M, Chowdhury S . Cell survival and metastasis regulation by Akt signaling in colorectal cancer. Cell Signal. 2013; 25(8):1711-9. PMC: 3686084. DOI: 10.1016/j.cellsig.2013.03.025. View

11.

Suzuki Y, Shirai K, Oka K, Mobaraki A, Yoshida Y, Noda S . Higher pAkt expression predicts a significant worse prognosis in glioblastomas. J Radiat Res. 2010; 51(3):343-8. DOI: 10.1269/jrr.09109. View

12.

Crouthamel M, Kahana J, Korenchuk S, Zhang S, Sundaresan G, Eberwein D . Mechanism and management of AKT inhibitor-induced hyperglycemia. Clin Cancer Res. 2009; 15(1):217-25. DOI: 10.1158/1078-0432.CCR-08-1253. View

13.

Zhu L, Hu C, Li J, Xue P, He X, Ge C . Real-time imaging nuclear translocation of Akt1 in HCC cells. Biochem Biophys Res Commun. 2007; 356(4):1038-43. DOI: 10.1016/j.bbrc.2007.03.092. View

14.

Agarwal A . How to explain the AKT phosphorylation of downstream targets in the wake of recent findings. Proc Natl Acad Sci U S A. 2018; 115(27):E6099-E6100. PMC: 6142228. DOI: 10.1073/pnas.1808461115. View

15.

Green C, Goransson O, Kular G, Leslie N, Gray A, Alessi D . Use of Akt inhibitor and a drug-resistant mutant validates a critical role for protein kinase B/Akt in the insulin-dependent regulation of glucose and system A amino acid uptake. J Biol Chem. 2008; 283(41):27653-27667. DOI: 10.1074/jbc.M802623200. View

16.

Tan S, Ng Y, Meoli C, Kumar A, Khoo P, Fazakerley D . Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes. J Biol Chem. 2011; 287(9):6128-38. PMC: 3307283. DOI: 10.1074/jbc.M111.318238. View

17.

Cho H, Mu J, Kim J, Thorvaldsen J, Chu Q, Crenshaw 3rd E . Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 2001; 292(5522):1728-31. DOI: 10.1126/science.292.5522.1728. View

18.

Lucic I, Rathinaswamy M, Truebestein L, Hamelin D, Burke J, Leonard T . Conformational sampling of membranes by Akt controls its activation and inactivation. Proc Natl Acad Sci U S A. 2018; 115(17):E3940-E3949. PMC: 5924885. DOI: 10.1073/pnas.1716109115. View

19.

Ebner M, Lucic I, Leonard T, Yudushkin I . PI(3,4,5)P Engagement Restricts Akt Activity to Cellular Membranes. Mol Cell. 2017; 65(3):416-431.e6. DOI: 10.1016/j.molcel.2016.12.028. View

20.

Parker L, Levinger I, Mousa A, Howlett K, de Courten B . Plasma 25-Hydroxyvitamin D Is Related to Protein Signaling Involved in Glucose Homeostasis in a Tissue-Specific Manner. Nutrients. 2016; 8(10). PMC: 5084018. DOI: 10.3390/nu8100631. View